IRONWOOD PHARMACEUTICALS, INC. Revenue Recognition, Milestone Method, Revenue Recognized
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Revenue Recognition, Milestone Method, Revenue Recognized of $76.44 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes
us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized · last filed 2015-02-18
- IRONWOOD PHARMACEUTICALS, INC. revenue recognition, milestone method, revenue recognized for fiscal 2014 was $76.44M, a 234.06% increase from fiscal 2013.
- IRONWOOD PHARMACEUTICALS, INC. revenue recognition, milestone method, revenue recognized for fiscal 2013 was $22.88M, a 84.77% decline from fiscal 2012.
- IRONWOOD PHARMACEUTICALS, INC. revenue recognition, milestone method, revenue recognized for fiscal 2012 was $150.25M.
| Period end | Revenue Recognition, Milestone Method, Revenue Recognized 12 month |
|---|---|
| 2014-12-31 | $76.44M 10-K · filed 2015-02-18 |
| 2013-12-31 | $22.88M 10-K · filed 2015-02-18 |
| 2012-12-31 | $150.25M 10-K · filed 2015-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |